Cargando…
Efficacy of a Commercial PCV2a Vaccine with a Two-Dose Regimen Against PCV2d
Porcine circovirus type 2, the causative agent of porcine circovirus associated diseases (PCVAD), consists of three major genotypes PCV2a, 2b and 2d. Current commercial vaccines contain the first-identified PCV2a’s capsid protein or whole virions. Outbreaks of PCVAD, caused by the recently identifie...
Autores principales: | Kolyvushko, Oleksandr, Rakibuzzaman, AGM, Pillatzki, Angela, Webb, Brett, Ramamoorthy, Sheela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789767/ https://www.ncbi.nlm.nih.gov/pubmed/31261743 http://dx.doi.org/10.3390/vetsci6030061 |
Ejemplares similares
-
Targeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine
por: Rakibuzzaman, AGM, et al.
Publicado: (2020) -
Harnessing the Genetic Plasticity of Porcine Circovirus Type 2 to Target Suicidal Replication
por: Rakibuzzaman, Agm, et al.
Publicado: (2021) -
Development of a differential multiplex real-time PCR assay for porcine circovirus type 2 (PCV2) genotypes PCV2a, PCV2b and PCV2d
por: Wang, Yin, et al.
Publicado: (2020) -
A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines
por: Bandrick, Meggan, et al.
Publicado: (2022) -
Genotype Shift of Malaysian Porcine Circovirus 2 (PCV2) from PCV2b to PCV2d within a Decade
por: Tan, Chew Yee, et al.
Publicado: (2022)